JEFFREY E GERSHENWALD to Piperazines
This is a "connection" page, showing publications JEFFREY E GERSHENWALD has written about Piperazines.
Connection Strength
0.043
-
Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer. 2008 Sep 02; 99(5):734-40.
Score: 0.043
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.